Jim Cramer Advises Viewers On AstraZeneca, Juno Therapeutics, Enbridge Energy Partners, Lockheed Martin And Microsoft

By: via Benzinga
On CNBC's Mad Money, Jim Cramer said that AstraZeneca plc (ADR) (NYSE: AZN) is in the midst of a major change and it has a nice ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.